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Abstract: Multiwavelength UV-visible transmission spectrophotometry is a 
useful tool for the examination of micron-size particle suspensions in the 
context of particle size and chemical composition. This paper reports the 
reliability of this method to characterize the spectra of purified red blood 
cells  both  in  their  physiological  state  and  with  modified  hemoglobin 
content. Previous studies have suggested the contribution of hypochromism 
on  the  particle  spectra  caused  by  the  close  electronic  interaction  of  the 
encapsulated  chromophores.  Our  research  shows,  however,  that  this 
perceived  hypochromism  can  be  accounted  for  by  considering  two 
important issues: the acceptance angle of the instrument and the combined 
scattering and absorption effect of light on the particles. In order to establish 
these ideas, spectral analysis was performed on purified and modified red 
cells where the latter was accomplished with a modified hypotonic shock 
protocol  that  altered  the  hemoglobin  concentration  within  the  cells. 
Moreover, the Mie theory was used to successfully simulate the spectral 
features and trends of the red cells. With this combination of experimental 
and theoretical exploration, definition of hypochromism has been extended 
to two subcategories. 
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1 Introduction 
Multiwavelength  ultraviolet-visible  (UV-vis)  spectrophotometry  is  a  rapid,  reliable  and 
effective tool for the qualitative and quantitative characterization of macroscopic particles in 
suspension [1–5]. The optical density (OD) spectrum of turbid systems depends on both its 
absorption and scattering components [6,7]. While an OD transmission spectrum of a small 
chromophore in solution is composed mainly of absorption, large particles in a suspension 
exhibit  more  pronounced  scattering  along  with  absorption  [6–8].  Such  properties  make 
suspended particle systems more complex to model in terms of their physical attributes and 
make  interpretation  of  the  spectrum  equally  problematic.  The  light  scattering  theory  of 
electromagnetic radiation has been shown to provide an effective approach to examining the 
particle  suspensions  including  polymers  [9],  molecular  aggregates  [10–12],  and 
microorganisms [13–15]. Successful use of the theory to model multiwavelength spectra of 
particles  requires  the  knowledge  of  several  important  parameters  including  the  chemical 
composition, particle number, particle size, and particle size distribution (PSD), all of which 
can be acquired experimentally. 
From  a  clinical  standpoint,  a  rapid  and  dependable  blood  screening  method  for 
determining  hematologic  parameters  and  detecting  abnormalities  that  surpasses  current 
technology  would  be  medically  useful.  Accurately  interpreted  multiwavelength  UV-vis 
technology shows the promise of providing such improvements. Whole blood is a complex 
particle  suspension  with  erythrocytes  (red  blood  cells  [RBC])  being  the  major  particle 
component  (~45%  v/v)  [16].  The  erythrocytes  contain  mainly  hemoglobin,  a  strongly 
chromophoric  protein  that  constitutes  approximately  98%  (w/w)  of  the  total  encapsulated 
protein [16]. The optically dense nature and the abundance of erythrocytes make it the focus 
for the spectral characterization of whole blood. 
In order to obtain a more comprehensive understanding of whole particle absorption and 
scattering  on  a  macroscopic  level,  a  combination  of  experimental  techniques  and 
mathematical  modeling  was  used  to  examine  data  on  the  spectral  characteristics  of 
erythrocytes. Studies had indicated the significance of hemoglobin concentration on the red 
cell  spectrum  [17,18]. Thus,  the  strategy  of  this  research  has  been  to  explore  the  optical 
behavior of dilute isolated red cells not only at physiological hemoglobin levels (33% w/v), 
but as cells modified to contain reduced hemoglobin concentrations. Modeling the red cell 
spectra using the theory of electromagnetic radiation to account for the combined absorption 
and scattering components of the spectra provides the ability to predict qualitative spectral 
changes by  manipulating  important parameters  such as the  hemoglobin concentration and 
particle size to successfully estimate a spectrum that is in good agreement with experimental 
data [6,8]. In order to achieve this level of realization, it is important to understand both how 
the  data  is  obtained  and  processed,  and  to  make  informed  assumptions  about  the 
intermolecular interactions of the hemoglobin under physiologically concentrated conditions. 
Hence, two important issues have been considered in this investigation: 1) hypochromism and 
2) instrumental setup. 
Hypochromism, or more appropriately observed hypochromism is a general term used to 
describe  the  attenuation  of  the  absorption  component  (and  hence  that  of  the  observed 
extinction  coefficient)  typically  associated  with  the  presence  of  a  chromophore  in  high 
concentrations  [19,20].  Historically,  certain  strongly  absorbing  chromophores  capable  of 
close association have been shown to exhibit molecular hypochromism, a reduction in the 
absorption when the molecules are in close proximity of one another [20]. The phenomenon 
has  been  suggested  to  be  present  in  strongly  absorbing  biological  constituents  such  as 
chlorophyll [21,22], polynucleotides [23], and hemoglobin [24,25]. In the most well studied 
system, polynucleotides, the molecular hypochromic effect has been explained in terms of 
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absorptive distortions due to molecular dipolar interactions [21] or the physical overlap of π 
orbitals of stacked chromophores [26]. It has also been attributed to the screening of radiation 
by  adjacent  molecules  [27].  Regardless  of  the  mechanism,  the  fundamental  cause  of  the 
hypochromism  of  the  polynucleotides  stems  from  their  close,  stacked  nature.  This  fixed 
juxtaposition of the nucleotide bases has been shown to evoke a hypochromic effect of up to 
28% (λmax = 260 nm) for an oligoadenine [28] or up to 60% for a helical polynucleotide [29]. 
For hemoglobin in erythrocytes, Vekshin (1999) reported a decrease in absorption of up to 
70% (λmax ~415nm) [24]. Contrary to the closely packed and relatively fixed nucleotides of a 
double helix where the partially stacked bases are in Van der Waals contact [30], hemoglobin 
encapsulated  in  red  blood  cells  presumably  exist  as  independent  proteins  with  their 
intermolecular distance estimated to be 62–75 Å (approximately the width of one molecule) 
[31].  Under  such  conditions,  random  collisions  are  prevalent  but  the  effect  of  organized 
molecular hypochromism is perhaps questionable. 
The  second  issue  in  the  characterization  of  erythrocytes  is  related  to  the  setup  of  the 
spectrophotometer  and  the  manner  in  which  the  transmission  data  is  captured. 
Multiwavelength spectra is generally a more powerful tool compared to single wavelength 
analysis since given its greater information content, it offers the ability to elucidate multiple 
parameters  for  the  characterization  of  a  suspended  system.  Optical  scattering  analyses  of 
erythrocytes have typically been limited to a single wavelength [32] or to a small number of 
select wavelengths [17,33,34], while multiwavelength representations have been reported as 
diffuse  spectra  [24,25].  Diffuse  spectra  results  from  the  acquisition  of  a  large  amount  of 
scattered light in colloidal systems and is typically defined by a wide angle of acceptance of 
the detector [35]. The collection of diffuse scattering plays an important role in the features of 
an  optical  density  spectrum  of  a  macro-particulate  system.  Differences  in  the  amount  of 
captured light (due to differences in instrumental arrangement) are represented by variations 
in spectral features in terms of overall intensity and changes in absorbance peaks. As the 
spectrophotometer  is  modified  to  collect  more  of  the  scattered  light,  the  arrangement 
approaches the characteristics of an integrating sphere, a limiting case were scattered light at 
essentially  all  angles  is  captured  [6].  The  resulting  spectrum  from  the  integrating  sphere 
would  represent  the  absorption  component  of  the  particulate  sample  with  the  scattering 
component being accounted for as background. Here the absorption bands of the encapsulated 
hemoglobin show hypochromicity  when compared to the spectrum of free hemoglobin in 
solution.  This  phenomenon  is  a  scattering-related  effect  of  large  particles  that  can  be 
accounted  for  by  using  the  scattering  theory  and  is  classified  under  a  novel  category  of 
observed hypochromism designated as macroscopic hypochromism (see Theory section for 
formal  definition).  Our  experimental  evidence  as  well  as  previous  work  done  on 
macromolecules (polystyrene, proteins) [9,12] support the notion that instances of perceived 
molecular hypochromism reported in encapsulated particle systems can be explained in terms 
of light scattering and instrumental configuration. 
Herein,  we  examine  the  use  of  multiwavelength  scattering  and  absorption  data  of  red 
blood cells measured  with both large and small angles of acceptance using commercially 
available  UV-visible  spectrophotometers.  The  data  presented  suggest  that  what  has  been 
described as hypochromicity for erythrocytes can be explained by 1) considering the angle of 
acceptance and 2) implementing a model based on the theory of electromagnetic radiation 
which  accounts  for  the  absorption  and  scattering  components  of  the  cell  suspension. 
Application of the model shows that the calculated spectra of unmodified and hypotonically 
modified erythrocytes are in good agreement  with the empirical spectra in terms of  their 
trends and spectral features. 
1.1. Experimental approach 
A protocol for the red cell permeabilization (by hypotonic shock) experiments was established 
where  the  conditions  of  the  modifications  were  controlled  in  such  a  manner  so  that  the 
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resulting  concentration  of  the  encapsulated  hemoglobin  could  be  manipulated  as  desired. 
Similar methods have been reported of using hypotonic exchange to render red blood cells 
transiently permeable to enable the passing of high-molecular weight molecules across the 
membrane [36–39]. In contrast, the aim of our modified protocol was to allow the hemoglobin 
to permeate out of the cells to different degrees, achieving resealed cell samples over a range 
hemoglobin mass fractions. While the erythrocytes are suspended in an isotonic phosphate 
buffered saline (PBS), the internal osmotic pressure (Pi) is constant with that of the external 
medium (Pe). When a hypotonic buffer is introduced to the cells (Pi > Pe), basic colligative 
property states that the water will flow into the cell to achieve equilibrium. If the buffer is 
sufficiently hypotonic, the force of the expanding cell membrane will initiate transient pores 
of 200–500 Å to allow the hemoglobin to pass out of the cell [39]. In order to reseal the cells, 
the osmotic pressure of the medium is reversed such that the pores are closed and the system 
returns to osmotic equilibrium. The resulting encapsulated hemoglobin concentration of the 
resealed  cells  is  controlled  by  the  volume  of  the  administered  hypotonic  buffer  and  the 
duration of the hypotonic shock. It has been suggested that of the initial cell population, 
approximately 45–60% of the permeabilized cells maintain the capability reseal depending on 
the  temperature  of  the  experiment  [40].  The  ability  obtain  encapsulated  hemoglobin 
concentrations  from  physiological  values  (~0.33  mass  fraction)  down  to  very  low  mass 
fractions  of  ~0.05  provides  a  valuable  opportunity  for  the  fundamental  investigation  of 
hypochromism. 
2. Materials and methods 
2.1. Erythrocyte harvesting 
EDTA-treated whole blood units from human donors were obtained by gracious contribution 
from the Florida Blood Services (St. Petersburg, FL). Typically, the blood samples were used 
for experiments within 48 hours of the donation. The erythrocytes were isolated from each 
unit by a standard two-step protocol performed by blood bank personnel. The first was a 
leukocyte depletion step in which the whole blood unit was passed through a standard leuko-
reducing  filter  (Sepacell  Pre-Storage  Leukocyte  Reduction  Set  for  Red  Cells,  Baxter 
Healthcare  Corp.,  Fenwal  Division,  IL).  The  second  step  was  a  thorough  washing  that 
removed platelets and replaced the plasma and its components with isotonic (0.9%, pH 7.0-
7.2)  phosphate  buffered  saline  (PBS)  (Nerl  Diagnostics,  RI)  by  employing  cycles  of 
centrifugation (1500 x g) and re-suspension in PBS. 
2.2. Hypotonic modification of erythrocytes 
Hypotonic permeation/restoration of red cells was accomplished using a modified version of 
previously published procedures [40,41]. Briefly, the washed red cells (~5 ml) were gently 
packed by centrifugation for approximately 5 minutes. The packed cells were then carefully 
aliquotted  to  varying  volumes  of  hypotonic  7  mM  PB  (phosphate  buffer  (pH  7.2)).  For 
example the ratios of hypotonic buffer volume to packed cell volume ranged from 0.75:1 to 
8:1. The higher the hypotonic buffer volume, the lower the resulting concentration of the 
hemoglobin  was  in  the  resealed  cells.  In  order  to  obtain  the  most  dilute  hemoglobin 
concentrations, the packed cells were treated with large amounts of hypotonic buffer and kept 
in  ice  for  20  minutes.  Following  the  permeation  and  equilibration  of  the  cells,  a  high 
concentration PBS (typically 1.0–2.0%) was used to adjust the sample tonicity back to 0.9% 
and the cells were allowed to reseal for 45 minutes in 37°C. The restored cells were harvested 
via centrifugation and washing (three cycles). After the third washing, the packed cells were 
re-suspended  in  isotonic  PBS  to  an  approximate  volume  ratio  of  1:1  and  kept  at  room 
temperature  during  the  spectrophotometric  analysis.  The  samples  were  typically  analyzed 
within an hour post-preparation. Spectral reproducibility of the samples was confirmed by 
performing replicates of the resealing experiment in parallel reaction vessels. 
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2.3. Spectrophotometric analysis of whole blood and resealed cells 
Multiwavelength  UV-visible  spectrophotometric  data  (190–1100  nm)  were  collected  for 
whole blood and washed red cell samples which were diluted to 4000 cells/μl in isotonic PBS. 
This is a concentration that was determined to give the maximum intensity for the optical 
density without departing from the linear range of the instrument (upper OD limit ~1.2). The 
Agilent 8453 diode array spectrophotometer was used to acquire a majority of the data and 
has an acceptance angle of approximately 2°. The integration time (time of scan) was adjusted 
to 15 seconds with spectra being acquired 10 times in one second, hence the resulting spectra 
was an average of 150 scans. Samples were read in a standard 3.5 ml quartz cuvette with a 1 
cm  pathlength  (Starna  Cells  Inc.,  CA)  at  room  temperature.  Prior  to  sampling,  the 
spectrophotometer was first blanked to correct for ambient light conditions. The sample was 
then  solvent-corrected  by  taking  a  spectrum  of  approximately  2  ml  of  the  solvent  and 
programming  the  software  to  subtract  this  solvent  spectrum  from  each  scanned  sample. 
Suspensions of resealed red cells were treated in the same manner as unmodified red cells for 
consistency. 
2.4. Diffuse transmission spectra 
Diffuse  spectra  were  obtained  using  the  Perkin-Elmer  Lambda  900  (Perkin-Elmer,  CT) 
spectrophotometer. The sample cuvette was placed in front of an integrating sphere module 
and  the  diffuse  spectra  was  acquired  by  the  light  being  transmitted  across  the  sphere 
(acceptance  angle  >  2°).  The  Perkin-Elmer  Lambda  18  fitted  with  an  integrating  sphere 
module (RSA-PE-18, Labsphere, NH) was used to collect all of the scattered light by the cell 
suspension. The spectra acquired by the three modes of data collection were compared and 
analyzed for a better understanding of instrumental configuration. 
2.5. Standard hematology analysis 
Blood samples were also examined using a hematology analyzer model 9010+ (Serono-Baker, 
PA) for corroboration with spectral data. The instrument uses an impedance based technology 
for cell counting and provides parameters such as red blood cell counts, mean corpuscular 
volume  (MCV),  hematocrit  (HCT),  and  mean  corpuscular  hemoglobin  concentration 
(MCHC).  The  hematology  analyzer  provides  independent  corroborating  data  for  the 
spectroscopy methods. 
3. Theory 
3.1. Angular scattering predictions 
The  interaction  of  light  with  particles  results  in  absorption  and  scattering  phenomena; 
particles scatter light in all directions and, depending on the experimental set-up, changes in 
the properties of the scattered light relative to the incident light may be measured as function 
of the observation angle. For finite aperture detectors, the angular resolution of the scattered 
light  depends  on  the  acceptance  angle  of  the  detector. Therefore  the  detector  response  is 
proportional to a weighted average of the scattered intensity over the angles defined by its 
aperture; a limiting case being measurements with an integrating sphere where essentially all 
scattered light is measured and subtracted from the transmitted light to obtain estimates of the 
attenuation due to absorption. The angle of acceptance is defined in Fig. 1 and it is related to 
the radius of the detector and the distance of the sample to the detector. Particles larger than 
the wavelength of the incident radiation are known to forward scatter light [6,7] and in the 
case of erythrocytes upwards of 97% of the scattered light will fall within 5° relative to the 
direction of the incident light. This is demonstrated in Fig. 2 where the predicted angular 
scattering spectrum calculated using Mie theory is shown. In this case zero degrees represent 
the  direction  of  incident  light.  The  inset  shows  a  semi-logarithmic  plot  elucidating  the  
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Fig. 1. Schematic representation of the angle of acceptance. The radius of the detector and the 
distance of the sample to the detector determine the amount of scattered light captured by the 
spectrophotometer. 
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
1.00
0 20 40 60 80 100 120 140 160 180
Scattering Angle
N
o
r
m
a
l
i
z
e
d
 
I
n
t
e
n
s
i
t
y
1.0E-08
1.0E-07
1.0E-06
1.0E-05
1.0E-04
1.0E-03
1.0E-02
1.0E-01
1.0E+00
0 20 40 60 80 100 120 140 160 180
Scattering Angle
l
o
g
 
(
N
o
r
m
a
l
i
z
e
d
 
I
n
t
e
n
s
i
t
y
)
 
Fig. 2. Angular scattering prediction for an equivalent sphere red cell. The large plot is a linear 
plot and the inset represents a semi-logarithmic depiction of the same plot. A majority of the 
scattered light is directed in the forward direction within five degrees. 
oscillatory features of scattering at larger angles. It is evident that careful consideration must 
be  given  to  the  acceptance  angle  of  the  detector  when  interpreting  transmission  data, 
particularly because the  shape and amplitude of the spectral features can be considerably 
affected and thus lead to erroneous conclusions [6,35]. The implications of the acceptance 
angle when measuring red blood cells are seen in our experiments (Figs. 7–9 below); notice 
that the spectral features for a small angle of acceptance spectrometer and for an integrating 
sphere are quite different and distinct from the spectrum of free hemoglobin in solution. It is 
also  evident  that  spectral  comparisons  for  the  assessment  of  hypochromicity  should  be 
conducted on the same basis (i.e., with equivalent instrumentation). Furthermore, given that 
considerable  scattered  light  is  admitted  into  the  detector  is  appropriate  to  redefine 
hypochromicity at two levels: 
•  Macroscopic  hypochromicity  which  is  due  to  changes  in  scattered  light  and  as 
consequence is proportional to the size of the scattering elements. 
#148296 - $15.00 USD Received 26 May 2011; revised 30 Jun 2011; accepted 30 Jun 2011; published 1 Jul 2011
(C) 2011 OSA 1 August 2011 / Vol. 2,  No. 8 / BIOMEDICAL OPTICS EXPRESS  2132  8 
• Microscopic or molecular hypochromicity which is due to the electronic interactions 
resulting from close proximity of chromophoric groups and therefore a function of 
the chromophore concentration within the particle. 
Based on the above definitions, a chromophoric group within a particle (i.e., hemoglobin in 
red blood cells) will experience hypochromicity when the observed absorption coefficient of 
the  encapsulated  chromophore  is  smaller  than  the  absorption  coefficient  of  the  same 
chromophore in dilute solution. The implication of dilute solution is that, statistically, the 
likelihood  of  one  molecule  screening  other  molecules  is  negligible.  Given  that  finite 
acceptance  angle  detectors  admit  a  considerable  amount  of  scattered  light,  to  assess 
hypochromicity the interpretation of the spectral data should be done within the context of a 
scattering model. 
3.2. Mie theory 
First published in 1907, Mie theory provides an exact solution to Maxwell’s equations for 
spherical particles [6–8] and contains information on the refractive index and the absorption 
coefficient  of  the  materials  constituting  the  particles,  as  well  as,  on  the  absorption  and 
scattering components of the transmitted light. The material properties are defined through the 
complex index of refraction m(λ) such that: 
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where n(λ) is the refractive index of the particle, n0(λ) is the refractive index of the medium, 
and  κ(λ)  is  the  absorption  coefficient  of  the  particle;  n(λ)  and  κ(λ)  constitute  the  optical 
properties of the particle. The equation that relates the particle size and the complex refractive 
index  to  the  absorption  and  scattering  components  of  the  transmitted  light  at  a  given 
wavelength (τ(λ)) is given by: 
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where Np is particle number per unit volume, D is the particle equivalent sphere diameter, 
f(D) is the particle size distribution (PSD), Qsca(α,m) and Qabs(α,m) are the Mie efficiencies. 
Mie  theory  is  ideally  suited  to  explore  possible  hypochromic  effects  because  it  has  no 
limitations relative to the size of the particles and no constraints relative to the magnitude of 
the optical properties. Furthermore, the absorption coefficient of chromophores in solution 
ε(λ),  or  Beer-Lambert  absorption  coefficient  is  directly  related  to  the  Mie  absorption 
coefficient κ(λ) through Bouger’s law (ε(λ) = 4πκ(λ) /λ) enabling direct comparison of the 
magnitude of the absorption coefficients for encapsulated chromophores and chromophores in 
solution. 
3.3. Simulations of erythrocytes 
The  Mie-based  turbidity  calculations  described  in  Eq.  (2)  (and  assuming  a  2°  acceptance 
angle) were implemented as a computer program capable of predicting the multiwavelength 
spectrum of red cells as well as the resealed cells. The simulation model required inputs for 
parameters that describe the red cell suspension including the cell volume fraction, the cell 
concentration in the cuvette, the equivalent sphere diameter of the cell, the mass fraction of 
the  protein  component,  the  optical  properties  (complex  refractive  index)  of  the  protein 
component, and the refractive index of the medium. Where applicable, the simulations (as 
well as experimental data) were normalized by dividing through the entire wavelength range 
by the area under the curve. The benefits of normalization were to eliminate the effects of 
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concentration on the spectra, and to visually elucidate features of spectra (in comparison to 
each other) that are not readily apparent on a linear scale. 
3.4. Estimation of optical properties 
Since  hemoglobin  is  the  dominant  chromophore  in  red  cells,  it  was  important  to  obtain 
reliable  optical  properties  for  the  protein.  Absorption  spectra  of  oxyhemoglobin  (Sigma-
Aldrich, Inc., St. Louis, MO) were obtained across a broad wavelength range (190–1100 nm) 
in numerous replicates. Statistical analysis ensured a small standard deviation of the samples 
(within 1–2% error) and the generated extinction coefficient (ε(λ)) was found to be in good 
agreement with published data [42]. The experimentally obtained ε(λ) was converted to (κ(λ)) 
(using Bouger’s Law) which was then was used to calculate the refractive index (n(λ)) part of 
m(λ) (Eq. (1) using the Kramers-Kronig transform [6] to give the complete optical properties 
of hemoglobin. Figure 3 illustrates the two components of the complex refractive index of 
hemoglobin as well as the refractive index of water. The latter was obtained from values 
reported by Thormaehlen et al. (1985) [43]. 
 
Fig. 3. Optical properties of oxyhemoglobin and the medium. Plot of the contents of an optical 
properties file for oxyhemoglobin over the wavelength range of 190-1100 nm. Plots include the 
absorption coefficient (κ(λ)) and refractive index (n(λ)) of hemoglobin and the refractive index 
(n0(λ)) of water. 
3.5. Sensitivity analysis: varying MCV 
The theoretical calculations based on Mie theory were used to examine the sensitivity of the 
spectra  to  changes  in  the  cell  size  (MCV).  The  simulation  varied  the  MCV  over  the 
physiological range of 80–100 fl [44]. The MCHC (0.33 mass fraction) and the hematocrit 
(0.45 volume fraction) were both held constant throughout the simulations. The MCV were  
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Fig. 4. Simulated spectra of erythrocytes at varying MCV at constant high MCHC (0.33 mass 
fraction). The MCV was varied in the physiological range of 80–100 fl. The volumes were 
expressed in the model as the equivalent sphere diameter. The spectra were normalized to 
eliminate the effects of number based cell concentration. 
represented using the diameters of spheres of equivalent volume (e.g. 80 fl has a spherical 
diameter  of  5.35  x  10
4  cm).  Figure  4  shows  the  result  of  the  simulation,  normalized  to 
eliminate effects due to particle concentration differences. As the sizes increased, the trend in 
the optical density showed a flattening of the spectra. The overall features stayed the same but 
the region above 600 nm showed small but consistent decreases in the slope with increasing 
particle size. In the 190–600 nm region, the larger cells exhibited a lower OD than the smaller 
cells. Thus, changes in the MCV within the physiological range had a detectable impact on 
the  simulated  spectra  when  the  hemoglobin  concentration  was  high  (0.33  mass  fraction). 
Varying the MCV at low MCHCs in the low range of ~0.05 mass fraction (Fig. 5) showed 
smaller  changes  in  the  overall  spectra  compared  to  the  changes  seen  in  Fig.  4.  The 
hemoglobin peaks were well defined with the low MCHC. Overall, the spectra of the different 
MCVs overlapped across the entire wavelength range with the exception of the two large 
peaks at 223 and 417 nm. The intensity of these peaks increased with smaller particle sizes, 
however, the differences were slight. 
3.6. Sensitivity analysis: varying MCHC 
It  was  also  of  interest  to  examine  how  variations  in  the  encapsulated  hemoglobin 
concentration would affect the spectra as the MCV was held constant at 80 fl and the MCHC 
value was varied from the high physiological mass fraction (0.33) down to a mass fraction of 
0.05  (Fig.  6).  The  hematocrit  value  was  also  held  constant  at  the  physiological  volume 
fraction  of  0.45  thus  the  cell  number  was  invariant  throughout  the  simulation.  The  most 
compelling  trend  was  the  overall  increase  in  the  intensity  the  spectra  across  the  entire 
wavelength range as the MCHC increased. At the low MCHC values (0.05 and 0.09), the  
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Fig. 5. Simulated spectra of erythrocytes at varying MCV at constant low MCHC (0.05 mass 
fraction). The MCV was varied in the physiological range of 80–100 fl. The volumes were 
expressed in the model as the equivalent sphere diameter. The spectra were normalized to 
eliminate the effects of number based cell concentration. 
characteristic spectral features of free hemoglobin were visible [singlet at (417 nm) and the 
doublet (500~600 nm)] (compare to spectrum of free hemoglobin in solution in Figs. 7–9). 
Even  a  small  difference  in  mass  fractions  between  0.05  and  0.09  lead  to  a  substantially 
elevated spectrum for the 0.09 mass fraction. The features of the simulated spectrum were 
markedly affected as the mass fraction hemoglobin was increased from 0.09 to 0.20 with the 
hemoglobin peaks becoming less prominent. At physiological MCHC (0.33 mass fraction) the 
overall optical density was increased and further masked the characteristic hemoglobin peaks. 
4. Results 
4.1. Effects of instrumental setup on the spectra of erythrocytes and hemoglobin 
In combination with the simulations, the effect of changes in the MCV and MCHC was also 
examined  experimentally.  To  this  end,  it  was  necessary  to  first  study  the  effects  on  the 
spectrum of  spectrophotometer systems that captured different amounts of scattered light. 
Three commercially available instruments were examined: 1) the Agilent 8453 diode array 
spectrophotometer  captured  the  transmitted  light  at  a  small  (2°)  acceptance  angle,  2)  the 
Perkin-Elmer Lambda 900 spectrophotometer acquired data at larger (> 2°) angles (referred to 
as diffuse transmission spectra), and 3) the Perkin-Elmer Lambda 18 spectrophotometer was 
fitted with an integrating sphere module to collect light scattered at all angles by the sample. 
Figure 6 shows a solid curve representing a spectrum of purified, diluted red cells (4000 
cells/μl)  containing  a  physiological  hemoglobin  concentration  (33%  w/v)  taken  with  an 
Agilent  spectrophotometer.  The  dashed  curve  shows  the  spectrum  of  a  free  hemoglobin 
solution obtained by lysing the same concentration of red cells in a hypotonic buffer (7mM 
phosphate  buffer),  thus  the  total  mass  of  the  hemoglobin  was  constant  between  the  two  
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Fig. 6. Simulated spectra of erythrocytes at varying MCHC and constant MCV. The MCV was 
held constant at 80 fl and the hematrocrit at 0.45 mass fraction. The MCHC was varied from 
the physiological value of 0.33 (high range) and decreased to medium and low ranges. The 
spectra are expressed per unit cell. 
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Fig. 7. Small acceptance angle spectra comparing purified red cells and hemoglobin in solution 
acquired from an Agilent 8453 spectrophotometer with an acceptance angle of 2°. The RBCs 
were purified by washing whole blood by centrifugation and passing the suspension through a 
leuko-reduction filter. The RBC concentration is approximately 4000 cells/μl. The spectrum of 
the hemoglobin solution represents a concentration of ~0.12 mg/ml. 
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samples. All the spectra presented in this section were obtained in replicates of three with 
good reproducibility. The spectrum of the encapsulated hemoglobin exhibits a significantly 
greater  OD  throughout  the  entire  wavelength  range  compared  to  the  spectrum  of  the 
hemoglobin  solution,  however  it  lacks  the  prominent  absorption  peaks  that  define  free 
hemoglobin (characteristic hemoglobin peaks at 270, 337, 417, 547, and 575 nm). 
Figure 8 illustrates spectra of a blood sample diluted to the same concentration as Fig. 7 
but  measured  with Perkin-Elmer Lambda 900 spectrophotometer  with a larger acceptance 
angle than the Agilent. Two features are immediately apparent compared to the spectra in the 
previous  figure.  First  is  the  presence  of  prominent  hemoglobin  peaks  in  the  diffuse 
transmission  spectrum  of  the  red  cell  suspension,  whereas  these  peaks  in  Fig.  7  were 
combined with scattering features of the red cell. Second, the diffuse transmission spectrum of 
the suspension shows an overall lower spectral intensity across the entire wavelength range 
compared to the red cell spectrum taken with the smaller, 2° acceptance angle (Fig. 7). This is 
expected since more of the scattered light is received by the detector but the features of the 
scattered light are averaged over all angles accepted. 
Figure  9  represents  spectra  acquired  with  an  integrating  sphere.  In  this  arrangement, 
essentially all of the scattered light was collected, hence the resulting transmission spectrum 
reflected  solely  the  absorption  component  (hence  it  can  be  referred  to  as  an  absorption 
spectrum). The baseline of the absorption spectrum of the red cells overlapped that of the 
spectrum  of  the  true  hemoglobin  solution,  contrary  to  the  elevated  nature  of  the  diffuse 
transmission spectrum shown in Fig. 7. As expected, the hemoglobin peaks of the red cell 
absorption spectrum were more pronounced with the integrating sphere in comparison to the 
diffuse red cell spectrum, however, the peaks at 270, 337 and 417 nm were less intense than  
the peaks of the hemoglobin solution. The doublet at 547 and 575 nm showed good overlap 
between the whole and lysed red cell spectra. The differences in intensity have been attributed 
to molecular hypochromicity by several authors [24,25]. 
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Fig. 8. Diffuse spectra comparing purified red cells and hemoglobin in solution acquired from 
a  Perkin-Elmer  Lambda  900  spectrophotometer  with  an  acceptance  angle  >2°.  The  RBC 
concentration  is  approximately  4000  cells/μl  and  the  concentration  for  the  hemoglobin  in 
solution is ~0.12 mg/ml. 
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Fig.  9.  Diffuse  integrating  sphere  spectra  comparing purified  red  cells  and  hemoglobin in 
solution acquired from a Perkin-Elmer Lambda 18 spectrophotometer fitted with an integrating 
sphere. The RBC concentration is approximately 4000 cells/μl and the concentration for the 
hemoglobin in solution is ~0.12 mg/ml. 
Note that the disparities in the spectra of identical cell suspensions were based solely on 
the differences of the spectrophotometer configuration, bringing to light the importance of 
understanding the instrumental arrangement in relation to data interpretation. It should also be 
noted that the dissimilarities in spectra due to the spectrophotometers were only manifested 
with large scatterers (such as RBCs) whereas the spectrum of small particles like those of 
hemoglobin in solution  were essentially the  same  with all three instruments and that  this 
behavior  is  consistent  with  the  scattering  theories  [6,7].  Most  importantly,  the  spectrum 
obtained from the smaller acceptance angle contains more scattering-related information (size, 
refractive index of the particle) and can be readily modeled with the appropriate scattering 
theory. 
4.2. Comparisons of spectra between experimental and simulated data 
As indicated in the theory section, Mie theory has no limitations relative to the size of the 
particles and no constraints relative to the magnitude of the optical properties. Given the size 
of the red blood cells and that that hemoglobin is a strong chromophore, Mie theory has been 
used as an effective tool to examine the relationship between the spectral features and the 
physical parameters of the experimental red cell data. The experimental system was composed 
of spectra of purified, unmodified red blood cells as well as red cells containing hypotonically 
altered hemoglobin concentrations. The data was obtained using the 2° acceptance angle to 
maximize  information  content  of  the  spectra  relative  to  the  absorption  and  scattering 
components of the red blood cells. The experimental and simulated spectra were compared 
closely for consistencies in  features and trends. Moreover, replicates of the resealed cells 
samples indicated reproducibility of relevant hematologic parameters (MCV, MCHC) and the 
features of the accompanying spectra. 
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Fig. 10. Experimental data set of purified red cells in the high MCHC range with varying MCV 
values. The data set is normalized in the 230-900 nm range using the area under the curve 
method. The MCHC is expressed in mass fractions and the MCV in fl. The free hemoglobin 
solution spectrum is included as a reference. 
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Fig. 11. Simulated spectra mimicking the experimental data set from Fig. 6, normalized on a 
per  cell  basis.  The  MCHC  is  expressed  in  mass  fractions  and  the  MCV  in  fl.  The  free 
hemoglobin solution spectrum is included as a reference. 
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Figure 10 is a summary of experimental spectra of purified red blood cells selected for 
similar  MCHCs  in  the  physiological  range,  but  with  varying  MCVs.  The  spectra  were 
normalized to eliminate effects due to particle concentration. A free hemoglobin spectrum 
scaled to fit the normalized plot was included as a reference for comparison of the features. 
For comparison with the experimental data, the same MCHC/MCV values were simulated 
using the Mie theory (Fig. 11). 
A comparison between the curves A1 and A2 in Fig. 10 show a direct overlap of the two 
spectra, as well as in the simulated spectra (curves B1 and B2 of Fig. 11). Consistent with this 
data, examination of the hematologic parameters for the red cell samples revealed that the 
MCHC and MCV values were also similar for both curves. The trend of the experimental 
spectrum of 0.332/97.8 (A3) compared to the other samples was also simulated accurately 
(B3).  Compared  to  A2,  the  quantitative  difference  of  A3  was  significant  in  terms  of  the 
volume. Although the magnitude of difference between A2 and A3 was greater than their 
simulated  counterparts  (B2  and  B3),  the  direction  of  the  spectral  change  was  the  same. 
Consistent with trends shown by the simulations section, the A3/B3 spectrum was slightly 
flattened as a result of its higher MCV. The successful simulations of the MCV differences 
presented here were experimentally reproducible. 
The next step was to test the ability of the model to accurately simulate combinations of 
varying MCHC and MCV. Figure 12 represents a group of experimental data selected over a 
range of MCHCs (0.048–0.336 mass fraction) each accompanied by varying MCV quantities. 
The inset shows raw data with each sample diluted to a concentration of approximately 4000 
cells/μl. The large plot is normalized data designed to amplify the features of the spectra to  
 
 
Fig. 12. Experimental spectra of resealed cells with varying MCHC and MCV values. The 
MCHC  is  expressed  in  mass  fractions  and  the  MCV  in  fl.  The  inset  represents  the  raw 
experimental data with each sample adjusted to a concentration of approximately 4000 cells/μl. 
The large plot represents the normalized data where each raw data was divided through by the 
area under their respective curve. The normalized plot amplifies the features of the curves to 
facilitate visual comparison. 
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Fig. 13. Simulated spectra of resealed cells using the experimental MCHC and MCV values in 
Fig. 10. The MCHC is expressed in mass fractions and the MCV in fl. The inset represents 
simulations of the raw experimental data. The large plot represents the normalized data where 
each raw data was divided through by the area under the respective curves. The normalized 
plot amplifies the features of the curves to facilitate visual comparison. 
facilitate visual qualitative comparisons. As the MCHC increased, the overall optical density 
increased (inset). The differences in the MCV provided a more subtle contribution to the 
spectra. The normalized plot helped to show the emergence of the hemoglobin peaks as the 
encapsulated hemoglobin concentrations decrease. The lowest MCHC sample (C4) showed 
the highest, most pronounced hemoglobin peaks whereas the highest MCHC  sample (C1) 
exhibited a near absence of the characteristic peaks. The observed behavior is expected and 
consistent with the scattering theory; as the concentration of hemoglobin within the cell is 
decreased, so is the contrast of the particle relative to the suspending medium, which results in 
a decrease of the scattering contribution [6,7]. 
Figure 13 presents the simulations of the experimental spectra using the same MCHC and 
MCV values. The empirical trends are evident in the simulated spectra: 1) there is a flattening 
in the curve with increasing MCHC, 2) the hemoglobin peaks become more apparent with 
decreasing MCHC, and 3) the inset plots show that with a constant cell count, the increase in 
MCHC  generates  a  dramatic  increase  in  the  intensity  of  the  overall  spectrum.  The  good 
agreements  seen  between  the  experimental  and  simulated  spectra  of  the  unmodified  and 
hypotonically  modified  erythrocytes  indicate  the  effectiveness  of  the  scattering  theory  in 
describing the spectral features as functions of the size and the hemoglobin concentration. 
5. Discussion 
Historically, hypochromicity has been defined by electronic molecular interactions [21,23] 
and it has been hypothesized that the same effect is significant in encapsulated systems such 
as red cells [24,25]. Our study approached this question from the perspective of instrumental 
configuration  and  a  theoretical  interpretation  of  the  combined  absorption  and  scattering 
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phenomenon. It is generally accepted in optics that the angle of acceptance of the detector 
contributes significantly to the outcome of the spectral features when particles, the size of red 
blood  cells  or  mitochondria,  are  present  [2,6,21,35,45].  Although  the  importance  of  the 
detector aperture has been recognized it has not been incorporated as a key parameter in the 
interpretation  of  hypochromicity.  The  comparison  of  acceptance  angles  presented  herein 
shows clear differences in the spectra of red cells resulting from the amount of scattered light 
acquired by the detector. A configuration that collects a large amount of scattered light loses 
scattering information in the transmission spectrum because the intensities of the scattered 
light are averaged over the angles accepted by the detector. In contrast, small acceptance 
angle transmission spectra contain a better balance of absorption and scattering information. 
Since a transmission spectrum of a large particle suspension such as red cells is dominated 
by the scattering component an accurate description of the scattered light is necessary. In the 
case of the small angle transmission spectrum, scattered light not captured by the detector can 
be inferred using light  scattering theory (in our case, the Mie theory) to deconvolute the 
spectrum into its scattering (Qsca) and absorption (Qabs) components. Conversely, the spectrum 
can be  modeled to simulate the features and trends of the spectra, as it  was successfully 
demonstrated  herein  for  red  blood  cells.  In  accordance  with  the  theory  of  scattering  of 
electromagnetic radiation, the scattering and absorption efficiencies are additive (Qext = Qsca + 
Qabs).  Therefore,  as  the  relative  contribution  of  the  scattering  component  increases,  a 
concomitant decrease in the absorption component will be observed. This explains why the 
absorption spectrum obtained from the integrating sphere is lower in intensity than its free 
hemoglobin  counterpart;  the  encapsulated  system  is  dominated  by  scattering  and  thus 
attenuates the intensity of the absorption component (macroscopic hypochromism). Moreover, 
both Qsca and Qabs are functions of the size and complex refractive index [6–8]. It is therefore 
easy to see that variations in the cell volume and hemoglobin content affect the spectra as 
shown both experimentally and theoretically in this study. 
The fundamental concepts underlying the interpretation of the optical spectra of red blood 
cells  bring  to  light  the  need  to  extend  the  definition  of  observed  hypochromicity  on  two 
levels. The results in this study clearly show the presence of macroscopic hypochromism, 
which is an effect of scattered light. Thus far, simulations based on the Mie theory closely 
match  experimental  spectra,  suggesting  that  the  more  commonly  referenced  molecular 
hypochromism plays a small or perhaps an insignificant role in the optical activity of red cells 
and related particle systems. This remains to be seen as current work progresses to extend the 
scattering theory to implement an interpretation model for the quantitative assessment of red 
blood cells. 
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